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Abstract
Pemphigus vulgaris is a serious chronic mucocuta-
neous ailment. In recent decades advances in diagnostic and
therapeutic measures have led to a significant decline in
morbidity and mortality. However, with the advent of active
and prolonged immunotherapy involving corticosteroids,
there has been a rise in steroid-associated complications.
This has led to significant concern globally over the sensi-
ble use of treatment regimen in pemphigus patients. We
present a patient who underwent a massive pulmonary
embolism following over usage of corticosteroid therapy for
pemphigus vulgaris. Whilst the patient survived owing to
timely assessment and aggressive surgical intervention, the
need for cautious and judicious immunotherapy in pemphi-
gus is emphasized.
Introduction
Pemphigus vulgaris is a rare albeit serious autoim-
mune dermatological condition associated with significant
morbidity. Over the years, there has been a marked decline
in mortality owing to the advent of corticosteroid and
immunosuppressant therapy. This has, however, led to a
number of steroid-associated complications in these
patients. One of the gravest amongst these, is the occasion-
ally reported pulmonary embolism (PE). We present a
patient who underwent a massive PE, following overuse of
systemic corticosteroids for pemphigus vulgaris. Even
though timely and aggressive approach turned out to be life-
saving, the need for sensible immunotherapy usage is
emphasized. 
Case Report
A 50 years old lady presented to the emergency room
with complaints of shortness of breath, palpitations and
dizziness. She was a known case of pemphigus vulgaris and
was receiving systemic glucocorticoid therapy for the past
three months. There was no history of any pulmonary or
cardiac ailment. 
Upon assessment, she was found to be tachycardiac
and tachypneic. Physical examination was unremarkable,
only multiple vesiculobullous lesions of pemphigus were
seen on her trunk. Laboratory investigations were normal,
electrocardiography demonstrated supraventricular tachy-
cardia and rightward deviation of QRS axis along with ST
changes suggestive of right ventricular strain. Chest
roentgenography and ultrasonography were within normal
limits, apart from suggestion of mild bilateral pleural effu-
sion. Echocardiography revealed dilated right sided cardiac
chambers. High resolution computed tomography was sub-
sequently carried out showing an extensive thrombus with-
in the pulmonary trunk, with the clot extending from the
main pulmonary artery into both pulmonary arteries
(Figure). 
Figure. Hypodense thrombus, appearing as a filling defect extending from main pulmonary artery
and forming a cast in the left pulmonary artery.
Evidence of thrombosis within the superior vena
cava and right atrium was also observed. Bilateral pleural
effusion and atelectasis with focal infarction of the right
upper lobe was also established.
Taking into consideration the acute presentation and
substantiation of significant thrombosis, surgical interven-
tion was performed. Embolectomy was carried out under
cardiopulmonary bypass. In view of the patient's age and
comorbidity, an inferior vena caval filter was consequently
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deployed to obtain prophylaxis against future throm-
boembolic events. 
The patient recovery was uneventful. She was placed
on a modified immunosuppressant and glucocorticoid ther-
apy for pemphigus along with an anticoagulation regime.
During the ensuing period, she has documented a gradual
resolution of her dermatologic ailment with no further
embolic episodes. 
Discussion
Pemphigus refers to a group of diseases character-
ized by painful lesions caused by intraepidermal acantholyt-
ic structures in the skin and mucous membrane. The precise
pathophysiology remains unclear. It is a rare chronic muco-
cutaneous disease distinguished by intra-epithelial bullae,
owing to autoantibodies directed against proteins of the
desmosome-tonofilament complex between keratinocytes.
Of this group of autoimmune disorders, pemphigus vulgaris
is the most debilitating dermatitides.1 A chronic erosive
mucocutaneous disease, its molecular basis is due to pro-
duction of autoantibodies directed against adhesion mole-
cules (desmoglein 1 and 3) that belong to the cadherin fam-
ily.2 The lesions initially appear in oral mucosa in majority
of patients3 followed by blistering of the skin, which is often
painful. The differential diagnosis includes nonimmune
causes such as contact dermatitis, infections, insect bites
and bullous reactions to drugs. Pemphigus may be discrim-
inated by the age at which the disease first appears, the mor-
phology and distribution of the lesions and the presence or
absence of mucosal lesions and scarring. Because the clini-
cal presentations of blistering disorders are often similar,
special immunofluorescence tests are used to confirm the
diagnosis. 
In recent years there has been a rapid evolution in the
understanding of the pathophysiology of autoimmune blis-
tering diseases, with significant advancement in the devel-
opment of modern diagnostic techniques and new therapeu-
tic approaches. The emergence of concomitant corticos-
teroid and immunosuppressive therapy has decreased mor-
tality of pemphigus vulgaris from 90% to around 30%.1,4 At
the same time, prolonged use of the above mentioned regi-
men has resulted in the development of serious complica-
tions such as diabetes, ulceration, arterial hypertension, car-
diorespiratory disease, infection and sepsis. Even today,
rarely reported and greatly dreaded is the development of
pulmonary embolism (PE), which has been known to occur
with high doses of corticosteroids required to control the
disease process in pemphigus.5,6
PE is the most serious outcome of venous throm-
boembolism. Approach towards the patient requires a high-
degree of clinical suspicion, timely assessment and prompt
intervention. Asymptomatic embolisation is frequently
encountered, with dyspnea and tachycardia being the only
signs and symptoms. Physical examination may be decep-
tively normal and also lacking in the majority of cases is
absence of clinical evidence of thrombophlebitis. On clini-
cal grounds, therefore, a firm diagnosis of PE cannot be
made, mandating further assessment by laboratory and
imaging parameters.   
Electrocardiography typically specifies merely
tachycardia, showing right axis deviation only with severe
congestion of pulmonary vasculature. A variety of modali-
ties are now engaged in the diagnostic imaging algorithm of
PE including; chest radiography, ventilation/perfusion
(V/Q) scintigraphy, pulmonary angiography, and recently
computed tomography and magnetic resonance imaging.
Several biomarkers including d-dimers, troponins, and
natriuretic peptides may provide additional information.    
Chest radiographic findings in acute presentations
include focal oligemia, vascular enlargement, atelectasis,
pleural effusions, and air space opacities representing pul-
monary hemorrhage or infarction.7 The chest roentgenogram
can occasionally be suggestive of PE, but is more often non-
specifically abnormal.7 The main use of the chest radiograph
in the evaluation of suspected PE, is to exclude entities that
may simulate PE.7 Because of its availability and familiarity
the V/Q scan is the most frequently used noninvasive screen-
ing study for the diagnosis of acute PE in many centres glob-
ally.8 Pulmonary angiography however, remains the gold stan-
dard for the diagnosis of PE.7 CT and MR imaging techniques
probably will have more significant roles in the future in the
diagnosis and management of PE, but limited availability and
familiarity with these imaging modalities make it impractical
to currently recommend them as primary screening tools for
acute PE.    
Only about 22% of major pulmonary embolisms are
correctly diagnosed.9 Thrombolysis and anticoagulation
constitute the cornerstone of management. However, in
cases of massive and submassive thromboembolism surgi-
cal intervention is universally indicated. Indeed in acute
cases pulmonary embolectomy is a lifesaving therapeutic
alternative with a good long-term prognosis in patients who
survive the early perioperative period.10
While timely assessment and rapid intervention are
mandated in an acute event, it is believed that greatest
improvement in mortality from PE is likely to come from
improved and aggressive prevention and prophylaxis by the
critical care team. 
In conclusion our patient was a case of pemphigus
vulgaris who developed acute massive PE owing to exces-
sive corticosteroid use. Fortunately prompt evaluation and
early surgical intervention turned out to be lifesaving.
Implication is hence towards judicious and cautious use of
the treatment regimen in pemphigus with routine monitor-
ing and surveillance for potentially fatal conditions such as
thromboembolism. 
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